HEADER UNKNOWN FUNCTION 15-SEP-16 5TCK TITLE SECOND BROMODOMAIN FROM LEISHMANIA DONOVANI LDBPK.091320 COMPLEXED TITLE 2 WITH BROMOSPORINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: UNCHARACTERIZED PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 161-300; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LEISHMANIA DONOVANI (STRAIN BPK282A1); SOURCE 3 ORGANISM_TAXID: 981087; SOURCE 4 STRAIN: BPK282A1; SOURCE 5 GENE: LDBPK_091320; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-CODONPLUS-RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15-MHL KEYWDS BROMODOMAIN, STRUCTURAL GENOMICS CONSORTIUM (SGC), UNKNOWN FUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR L.-H.LIN,C.F.D.HOU,P.LOPPNAU,A.DONG,C.BOUNTRA,A.M.EDWARDS, AUTHOR 2 C.H.ARROWSMITH,R.HUI,J.R.WALKER,STRUCTURAL GENOMICS CONSORTIUM (SGC) REVDAT 2 24-JAN-18 5TCK 1 AUTHOR JRNL REMARK REVDAT 1 09-NOV-16 5TCK 0 JRNL AUTH L.-H.LIN,C.F.D.HOU,P.LOPPNAU,A.DONG,C.BOUNTRA,A.M.EDWARDS, JRNL AUTH 2 C.H.ARROWSMITH,R.HUI,J.R.WALKER, JRNL AUTH 3 STRUCTURAL GENOMICS CONSORTIUM (SGC) JRNL TITL SECOND BROMODOMAIN FROM LEISHMANIA DONOVANI LDBPK.091320 JRNL TITL 2 COMPLEXED WITH BROMOSPORINE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.84 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 20392 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1020 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.06 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.76 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2887 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2130 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2750 REMARK 3 BIN R VALUE (WORKING SET) : 0.2110 REMARK 3 BIN FREE R VALUE : 0.2490 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.75 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 137 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2161 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 171 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.86 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.34660 REMARK 3 B22 (A**2) : -0.34510 REMARK 3 B33 (A**2) : 3.69180 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.220 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.200 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.166 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.441 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.161 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4512 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 8064 ; 3.800 ; HARMONIC REMARK 3 TORSION ANGLES : 997 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 50 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 735 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4512 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 296 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5144 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 0.62 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.27 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.15 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 15.7918 55.8035 15.5496 REMARK 3 T TENSOR REMARK 3 T11: -0.2874 T22: -0.3052 REMARK 3 T33: -0.3469 T12: -0.0338 REMARK 3 T13: 0.0177 T23: 0.0038 REMARK 3 L TENSOR REMARK 3 L11: 0.7086 L22: 2.2351 REMARK 3 L33: 1.0182 L12: 0.1985 REMARK 3 L13: -0.0426 L23: 0.2752 REMARK 3 S TENSOR REMARK 3 S11: 0.0112 S12: -0.0443 S13: 0.0152 REMARK 3 S21: 0.0302 S22: 0.0111 S23: 0.0104 REMARK 3 S31: 0.0894 S32: -0.0495 S33: -0.0223 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 32.9637 83.6126 5.3673 REMARK 3 T TENSOR REMARK 3 T11: 0.0936 T22: 0.1216 REMARK 3 T33: 0.0870 T12: 0.0177 REMARK 3 T13: -0.0135 T23: 0.0111 REMARK 3 L TENSOR REMARK 3 L11: 0.2861 L22: 1.2537 REMARK 3 L33: 0.0800 L12: 0.5562 REMARK 3 L13: 0.1593 L23: 0.4263 REMARK 3 S TENSOR REMARK 3 S11: -0.0311 S12: 0.0172 S13: 0.0429 REMARK 3 S21: -0.1158 S22: 0.0152 S23: 0.1210 REMARK 3 S31: 0.0132 S32: 0.0049 S33: 0.0159 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5TCK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-SEP-16. REMARK 100 THE DEPOSITION ID IS D_1000224041. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUN-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN A200 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20521 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: ARCIMBOLDO REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE PROTEIN WAS CRYSTALLIZED AT 293 K REMARK 280 WITH 1% W/V TRYPTONE, 0.001 M SODIUM AZIDE, 0.05 M HEPES SODIUM REMARK 280 PH 7.0, 12% W/V POLYETHYLENE GLYCOL 3,350 WITH BROMOSPORINE REMARK 280 USING THE SITTING DROP METHOD., VAPOR DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 17.12250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.20600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.04300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.20600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 17.12250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.04300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 144 REMARK 465 HIS A 145 REMARK 465 HIS A 146 REMARK 465 HIS A 147 REMARK 465 HIS A 148 REMARK 465 HIS A 149 REMARK 465 HIS A 150 REMARK 465 SER A 151 REMARK 465 SER A 152 REMARK 465 GLY A 153 REMARK 465 ARG A 154 REMARK 465 GLU A 155 REMARK 465 ASN A 156 REMARK 465 LEU A 157 REMARK 465 TYR A 158 REMARK 465 PHE A 159 REMARK 465 GLN A 160 REMARK 465 GLY A 161 REMARK 465 MET B 144 REMARK 465 HIS B 145 REMARK 465 HIS B 146 REMARK 465 HIS B 147 REMARK 465 HIS B 148 REMARK 465 HIS B 149 REMARK 465 HIS B 150 REMARK 465 SER B 151 REMARK 465 SER B 152 REMARK 465 GLY B 153 REMARK 465 ARG B 154 REMARK 465 GLU B 155 REMARK 465 ASN B 156 REMARK 465 LEU B 157 REMARK 465 TYR B 158 REMARK 465 PHE B 159 REMARK 465 GLN B 160 REMARK 465 GLY B 161 REMARK 465 ALA B 162 REMARK 465 ALA B 163 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 180 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 192 CD OE1 OE2 REMARK 470 SER A 225 OG REMARK 470 SER A 227 OG REMARK 470 GLU A 261 CG CD OE1 OE2 REMARK 470 ARG B 168 CD NE CZ NH1 NH2 REMARK 470 ARG B 180 NE CZ NH1 NH2 REMARK 470 GLU B 192 CG CD OE1 OE2 REMARK 470 SER B 200 OG REMARK 470 LYS B 203 CG CD CE NZ REMARK 470 ARG B 207 NE CZ NH1 NH2 REMARK 470 LYS B 219 CD CE NZ REMARK 470 LYS B 259 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 230 -79.72 -93.18 REMARK 500 VAL B 230 -81.23 -89.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BMF A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BME A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SX A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BMF B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 804 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide BME B 802 and CYS B REMARK 800 205 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide SX B 803 and CYS B REMARK 800 253 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5TCM RELATED DB: PDB DBREF 5TCK A 161 300 UNP E9BA17 E9BA17_LEIDB 161 300 DBREF 5TCK B 161 300 UNP E9BA17 E9BA17_LEIDB 161 300 SEQADV 5TCK MET A 144 UNP E9BA17 INITIATING METHIONINE SEQADV 5TCK HIS A 145 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK HIS A 146 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK HIS A 147 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK HIS A 148 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK HIS A 149 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK HIS A 150 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK SER A 151 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK SER A 152 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK GLY A 153 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK ARG A 154 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK GLU A 155 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK ASN A 156 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK LEU A 157 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK TYR A 158 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK PHE A 159 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK GLN A 160 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK GLY A 161 UNP E9BA17 ALA 161 CONFLICT SEQADV 5TCK MET B 144 UNP E9BA17 INITIATING METHIONINE SEQADV 5TCK HIS B 145 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK HIS B 146 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK HIS B 147 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK HIS B 148 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK HIS B 149 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK HIS B 150 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK SER B 151 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK SER B 152 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK GLY B 153 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK ARG B 154 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK GLU B 155 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK ASN B 156 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK LEU B 157 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK TYR B 158 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK PHE B 159 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK GLN B 160 UNP E9BA17 EXPRESSION TAG SEQADV 5TCK GLY B 161 UNP E9BA17 ALA 161 CONFLICT SEQRES 1 A 157 MET HIS HIS HIS HIS HIS HIS SER SER GLY ARG GLU ASN SEQRES 2 A 157 LEU TYR PHE GLN GLY ALA ALA PRO PRO SER THR ARG GLU SEQRES 3 A 157 MET VAL GLN LEU VAL ASP SER LEU ASN ARG ARG GLU ASP SEQRES 4 A 157 GLY GLY ALA PHE SER VAL ASP VAL ALA GLU ALA TYR PRO SEQRES 5 A 157 ASP LEU ARG ASP SER TYR ARG LYS ILE CYS PRO ARG PRO SEQRES 6 A 157 MET ASN LEU ILE LEU MET ARG GLN ARG ALA LYS GLU GLY SEQRES 7 A 157 TYR TYR THR SER GLY SER ALA THR VAL TYR GLY ASP THR SEQRES 8 A 157 VAL ALA ALA SER LEU THR ARG LEU ARG GLU ASP ILE GLU SEQRES 9 A 157 LEU LEU VAL ARG ASN CYS ILE THR PHE ASN VAL LYS VAL SEQRES 10 A 157 GLU SER TRP VAL THR LEU ALA ARG SER PHE GLN ALA PHE SEQRES 11 A 157 ALA HIS ARG ARG VAL ASP ASP PHE VAL LEU ARG HIS ALA SEQRES 12 A 157 ALA PHE LEU ARG GLY THR THR MET GLY ALA GLU VAL TYR SEQRES 13 A 157 GLU SEQRES 1 B 157 MET HIS HIS HIS HIS HIS HIS SER SER GLY ARG GLU ASN SEQRES 2 B 157 LEU TYR PHE GLN GLY ALA ALA PRO PRO SER THR ARG GLU SEQRES 3 B 157 MET VAL GLN LEU VAL ASP SER LEU ASN ARG ARG GLU ASP SEQRES 4 B 157 GLY GLY ALA PHE SER VAL ASP VAL ALA GLU ALA TYR PRO SEQRES 5 B 157 ASP LEU ARG ASP SER TYR ARG LYS ILE CYS PRO ARG PRO SEQRES 6 B 157 MET ASN LEU ILE LEU MET ARG GLN ARG ALA LYS GLU GLY SEQRES 7 B 157 TYR TYR THR SER GLY SER ALA THR VAL TYR GLY ASP THR SEQRES 8 B 157 VAL ALA ALA SER LEU THR ARG LEU ARG GLU ASP ILE GLU SEQRES 9 B 157 LEU LEU VAL ARG ASN CYS ILE THR PHE ASN VAL LYS VAL SEQRES 10 B 157 GLU SER TRP VAL THR LEU ALA ARG SER PHE GLN ALA PHE SEQRES 11 B 157 ALA HIS ARG ARG VAL ASP ASP PHE VAL LEU ARG HIS ALA SEQRES 12 B 157 ALA PHE LEU ARG GLY THR THR MET GLY ALA GLU VAL TYR SEQRES 13 B 157 GLU HET BMF A 401 28 HET BME A 402 9 HET SX A 403 2 HET EDO A 404 10 HET BMF B 801 28 HET BME B 802 9 HET SX B 803 2 HET EDO B 804 10 HETNAM BMF BROMOSPORINE HETNAM BME BETA-MERCAPTOETHANOL HETNAM SX SULFUR OXIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN BMF ETHYL (3-METHYL-6-{4-METHYL-3-[(METHYLSULFONYL) HETSYN 2 BMF AMINO]PHENYL}[1,2,4]TRIAZOLO[4,3-B]PYRIDAZIN-8-YL) HETSYN 3 BMF CARBAMATE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 BMF 2(C17 H20 N6 O4 S) FORMUL 4 BME 2(C2 H6 O S) FORMUL 5 SX 2(O S) FORMUL 6 EDO 2(C2 H6 O2) FORMUL 11 HOH *171(H2 O) HELIX 1 AA1 SER A 166 SER A 176 1 11 HELIX 2 AA2 LEU A 177 ASN A 178 5 2 HELIX 3 AA3 ARG A 179 GLY A 183 5 5 HELIX 4 AA4 ASP A 189 TYR A 194 1 6 HELIX 5 AA5 LEU A 197 CYS A 205 1 9 HELIX 6 AA6 ASN A 210 GLU A 220 1 11 HELIX 7 AA7 LEU A 239 ASN A 257 1 19 HELIX 8 AA8 VAL A 260 ALA A 286 1 27 HELIX 9 AA9 ALA A 287 ARG A 290 5 4 HELIX 10 AB1 MET A 294 TYR A 299 1 6 HELIX 11 AB2 SER B 166 SER B 176 1 11 HELIX 12 AB3 LEU B 177 ASN B 178 5 2 HELIX 13 AB4 ARG B 179 GLY B 183 5 5 HELIX 14 AB5 ASP B 189 TYR B 194 1 6 HELIX 15 AB6 LEU B 197 CYS B 205 1 9 HELIX 16 AB7 ASN B 210 GLU B 220 1 11 HELIX 17 AB8 LEU B 239 ASN B 257 1 19 HELIX 18 AB9 VAL B 260 ALA B 286 1 27 HELIX 19 AC1 ALA B 287 ARG B 290 5 4 HELIX 20 AC2 MET B 294 TYR B 299 1 6 LINK SG CYS A 205 S2 BME A 402 1555 1555 2.04 LINK SG CYS A 253 S SX A 403 1555 1555 2.11 LINK SG CYS B 205 S2 BME B 802 1555 1555 2.02 LINK SG CYS B 253 S SX B 803 1555 1555 2.06 SITE 1 AC1 14 ASN A 257 SER A 262 TRP A 263 HOH A 503 SITE 2 AC1 14 HOH A 525 HOH A 540 GLU B 181 ASP B 182 SITE 3 AC1 14 GLY B 183 ALA B 185 PHE B 256 BMF B 801 SITE 4 AC1 14 BME B 802 SX B 803 SITE 1 AC2 1 CYS A 205 SITE 1 AC3 4 ALA A 185 CYS A 253 ASN A 257 BMF B 801 SITE 1 AC4 3 GLU A 244 GLU A 247 TYR A 299 SITE 1 AC5 11 GLU A 181 ASP A 182 GLY A 183 ALA A 185 SITE 2 AC5 11 BMF A 401 SX A 403 ASN B 257 SER B 262 SITE 3 AC5 11 TRP B 263 HOH B 915 HOH B 934 SITE 1 AC6 4 ARG B 202 THR B 234 ALA B 236 HOH B 947 SITE 1 AC7 9 BMF A 401 TYR B 201 ARG B 202 LYS B 203 SITE 2 AC7 9 ILE B 204 PRO B 206 ARG B 207 ASN B 252 SITE 3 AC7 9 HOH B 945 SITE 1 AC8 10 BMF A 401 ALA B 185 LEU B 249 VAL B 250 SITE 2 AC8 10 ARG B 251 ASN B 252 ILE B 254 THR B 255 SITE 3 AC8 10 PHE B 256 ASN B 257 CRYST1 34.245 74.086 106.412 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029201 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013498 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009397 0.00000